Kala Pharmaceuticals to Report Second Quarter 2019 Financial Results and Host Conference Call
July 30 2019 - 4:05PM
Business Wire
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical
company focused on the development and commercialization of
therapeutics using its proprietary AMPPLIFY™ mucus-penetrating
particle (MPP) Drug Delivery Technology, today announced that it
will report second quarter 2019 financial results on Tuesday,
August 6, 2019. Management will host a conference call and live
audio webcast to discuss these results and provide a business
update at 8:00 a.m. ET.
The dial-in numbers to access the conference call are
866-300-4091 (domestic) or 703-736-7433 (international) using the
conference ID 2677066. To access a live webcast and subsequent
archived recording of the call, please visit the “Investors &
Media” section on the Kala website at http://kalarx.com/.
About Kala Pharmaceuticals, Inc.
Kala is a biopharmaceutical company focused on the development
and commercialization of therapeutics using its proprietary
AMPPLIFYTM mucus-penetrating particle (MPP) Drug Delivery
Technology, with an initial focus on the treatment of eye diseases.
Kala has applied the AMPPLIFY Drug Delivery Technology to a
corticosteroid, loteprednol etabonate (LE), designed for ocular
applications, resulting in INVELTYS® which received FDA approval in
August 2018 for the treatment of inflammation and pain following
ocular surgery, and its lead product candidate, KPI-121 0.25%, for
the temporary relief of the signs and symptoms of dry eye disease,
for which a target action date under the Prescription Drug User Fee
Act (PDUFA) has been set by the United States Food and Drug
Administration (FDA) for August 15, 2019.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190730005810/en/
Investor: Hannah Deresiewicz
hannah.deresiewicz@sternir.com 212-362-1200 Media: Kari
Watson kwatson@macbiocom.com 781-235-3060
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From May 2024 to Jun 2024
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Jun 2023 to Jun 2024